Project Carcinome cutané à cellules de Merkel: Variabilité génétique du Polyomavirus associé Antoine Gessain
Project The role of a gradient of the chemokine CXCL12 in hematopoietic development and in a normal immune response. (Collaboration with F. Arenzana-Seisdedos, granted ANR funding) Paulo Vieira
Project Dynamic regulation of chromatin and transcription by HP1 Heterochromatin Proteins in relationship with RNA.
Project Circulating biomarkers in geographically diverse populations with varying rates of gastric cancer Eliette Touati
Project Upstream stimulating factors USF1 and USF2 in the host response to Helicobacter pylori infection : impact on gastric carcinogenesis Eliette Touati
Project ANR Patho-Methylome – The role of lysine methylation in host-pathogen interactions Jonathan Weitzman
Project FP7 Targeting the Leishmania kinome for the development of novel anti-parasitic strategies (LeishDrug) Gérald Spaeth
Project LeiSHield – A new collaborative action to determine prevalence, anticipate emergence and assess urbanization of cutaneous and visceral leishmaniasis in LeishRIIP partner countries Gérald Spaeth
Project ANR TransLeish – Discovery of druggable protein kinases in the protozoan parasite Leishmania donovani using hit compounds identified by phenotypic screening Najma Rachidi • Gérald Spaeth
Project ANR TranSig – Trans-signalling: A novel mechanism of Leishmania host cell immune evasion through the release of parasite signalling proteins Najma Rachidi
Project PTR 539 – A multilevel systems approach to elucidate the host-Leishmania interactome and to identify host targets for anti-leishmanial drug discovery Joo Hwan No
Project PTR 496 – Investigating the reciprocal relationship between macrophage inflammasome activity and intracellular Leishmania infection Eric Prina
Project Functional characterization of mosquito genes involved in dengue virus transmission identified by RNA-seq at the individual midgut level Louis Lambrechts
Project Multi-species mapping of influenza viruses cellular targets using high-throughput complementary strategies in a “One Health” perspective.